Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Red algae as an alternative for non-biodegradable plastic!

Decreased efficacy of AstraZeneca vaccines on S. African strains

Do we have a vaccine for HIV now?!!!

Red algae as an alternative for non-biodegradable plastic!
  • BiotechToday
  • World

Red algae as an alternative for non-biodegradable plastic!

bioxone February 12, 2021February 12, 2021

Richismita Hazra, Amity University Kolkata

Synthetic plastics have become an interminable hazard to the environment since the beginning of their use. Synthetic plastics contain such polymers which on interaction with water, generate toxic chemicals that are discharged into the surrounding environment. Although biodegradable products like sugarcane have been utilized for producing an alternative, scientists are in search of more such eco-friendly substitutes. So as to determine a feasible alternative, researchers have steered their findings and studies of marine biomass. 

Scientists from NIOT (National Institute of Ocean Technology) have developed a bio-plastic film from macroalgae and PEG-300 which is expected to scale down the usage or consumption of non-biodegradable plastics.

Kappaphycus alvarezii is a red algae that is of significant commercial importance. They are highly colloidal and can be easily and cheaply cultivated in a short period of time (about 45 days) without the involvement of chemicals or freshwater. They only require sunlight. This innovative bio-plastic would be potential as carrying bags and food packaging materials that would enable permeability of moisture and oxygen.

The plasticizer PEG-300 (Polyethylene Glycol) has been used along with this red algae by the research team in order to attain improved tensile strength. This plasticizer is an eco-friendly and non-toxic polymer that is useful in boosting thermos-plasticity. This innovative and novel bio-plastic exhibits matching levels of mechanical and physical properties with that of synthetic plastics. 

Also read:Decreased efficacy of AstraZeneca vaccines on S. African strains

Source- https://vigyanprasar.gov.in/isw/Development-of-biodegradable-plastic-from-marine-seaweed.html 

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Algae Biodegradable Macroalgae Ocean Technology plastics Pollution polymers Seaweed technology Toxic

One thought on “Red algae as an alternative for non-biodegradable plastic!”

  1. Pingback: Do we have a vaccine for HIV now?!!! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Do we have a vaccine for HIV now?!!!

bioxone February 12, 2021

CAMELIA BHATTACHARYYA, AMITY UNIVERSITY KOLKATA HIV or Human Immunodeficiency virus was first discovered in the early 1980s. It later became an epidemic and it still scares people since there’s still no vaccine known to protect us against it. Does that mean that the scientists and researchers are not trying to even make one? Well no. […]

HIV

Related Post

  • BiotechToday
  • World

How are infectious clones of Begomoviruses constructed?

BioTech Today July 4, 2021July 3, 2021

Ananya Ghosal, MAKAUT (WB) Agricultural sectors are being harmed by Begomoviruses which cause a huge loss to economically important crops. To prevent such losses, intricate studies of viral genomes and functions are needed. The genomes of viruses are directly exploited by infectious clone approaches and applications. The critical instrument for basic characterization of the notable […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Are the chimpanzees safe from newly discovered pathogens?

bioxone March 7, 2021March 7, 2021

-Souradip Mallick, National Institute of Technology, Rourkela Tacugama in Sierra Leone is the sanctuary for western chimpanzees, a critically endangered subspecies. This sanctuary is the hub of environmental education, ecotourism, and community conservation projects. Ninety-nine chimps permanently reside at Tacugama today. Among them, many of them were rescued as babies from the illegal wildlife trade. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Zolgensma: World’s most expensive life-saving drug approved

bioxone March 11, 2021March 11, 2021

Husna, Amity University Kolkata United Kingdom’s National Health Service (NHS) has approved the most expensive drug of ₹18 crores (£1.79 million) per dose to cure a rare genetic disorder. The drug Zolgensma, manufactured by Novartis Gene Therapies can treat Spinal Muscular Atrophy (SMA) which is a rare and often fatal genetic disease that causes paralysis […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy